These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 24146979)
1. Deletion of the eIF2α Kinase GCN2 fails to rescue the memory decline associated with Alzheimer's disease. Devi L; Ohno M PLoS One; 2013; 8(10):e77335. PubMed ID: 24146979 [TBL] [Abstract][Full Text] [Related]
2. PERK mediates eIF2α phosphorylation responsible for BACE1 elevation, CREB dysfunction and neurodegeneration in a mouse model of Alzheimer's disease. Devi L; Ohno M Neurobiol Aging; 2014 Oct; 35(10):2272-81. PubMed ID: 24889041 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms that lessen benefits of β-secretase reduction in a mouse model of Alzheimer's disease. Devi L; Ohno M Transl Psychiatry; 2013 Jul; 3(7):e284. PubMed ID: 23880880 [TBL] [Abstract][Full Text] [Related]
4. Phospho-eIF2α level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice. Devi L; Ohno M PLoS One; 2010 Sep; 5(9):e12974. PubMed ID: 20886088 [TBL] [Abstract][Full Text] [Related]
5. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice. Devi L; Ohno M Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558 [TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. O'Connor T; Sadleir KR; Maus E; Velliquette RA; Zhao J; Cole SL; Eimer WA; Hitt B; Bembinster LA; Lammich S; Lichtenthaler SF; Hébert SS; De Strooper B; Haass C; Bennett DA; Vassar R Neuron; 2008 Dec; 60(6):988-1009. PubMed ID: 19109907 [TBL] [Abstract][Full Text] [Related]
7. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice. Devi L; Ohno M Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928 [TBL] [Abstract][Full Text] [Related]
8. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice. Kimura R; Devi L; Ohno M J Neurochem; 2010 Apr; 113(1):248-61. PubMed ID: 20089133 [TBL] [Abstract][Full Text] [Related]
9. Genetic inhibition of phosphorylation of the translation initiation factor eIF2α does not block Aβ-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer's disease. Sadleir KR; Eimer WA; Kaufman RJ; Osten P; Vassar R PLoS One; 2014; 9(7):e101643. PubMed ID: 24992504 [TBL] [Abstract][Full Text] [Related]
10. 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease. Devi L; Ohno M Neuropsychopharmacology; 2012 Jan; 37(2):434-44. PubMed ID: 21900882 [TBL] [Abstract][Full Text] [Related]
11. Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway. Mouton-Liger F; Paquet C; Dumurgier J; Bouras C; Pradier L; Gray F; Hugon J Biochim Biophys Acta; 2012 Jun; 1822(6):885-96. PubMed ID: 22306812 [TBL] [Abstract][Full Text] [Related]
12. Suppression of eIF2α kinases alleviates Alzheimer's disease-related plasticity and memory deficits. Ma T; Trinh MA; Wexler AJ; Bourbon C; Gatti E; Pierre P; Cavener DR; Klann E Nat Neurosci; 2013 Sep; 16(9):1299-305. PubMed ID: 23933749 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer's disease. Devi L; Alldred MJ; Ginsberg SD; Ohno M PLoS One; 2012; 7(3):e32792. PubMed ID: 22403710 [TBL] [Abstract][Full Text] [Related]
14. Gastrodin suppresses BACE1 expression under oxidative stress condition via inhibition of the PKR/eIF2α pathway in Alzheimer's disease. Zhang JS; Zhou SF; Wang Q; Guo JN; Liang HM; Deng JB; He WY Neuroscience; 2016 Jun; 325():1-9. PubMed ID: 26987953 [TBL] [Abstract][Full Text] [Related]
15. Sex- and brain region-specific acceleration of β-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease. Devi L; Alldred MJ; Ginsberg SD; Ohno M Mol Brain; 2010 Nov; 3():34. PubMed ID: 21059265 [TBL] [Abstract][Full Text] [Related]
16. PERK and GCN2 contribute to eIF2alpha phosphorylation and cell cycle arrest after activation of the unfolded protein response pathway. Hamanaka RB; Bennett BS; Cullinan SB; Diehl JA Mol Biol Cell; 2005 Dec; 16(12):5493-501. PubMed ID: 16176978 [TBL] [Abstract][Full Text] [Related]
17. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice. Devi L; Ohno M Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043 [TBL] [Abstract][Full Text] [Related]
18. Pathogenesis and promising therapeutics of Alzheimer disease through eIF2α pathway and correspondent kinases. Moradi Majd R; Mayeli M; Rahmani F Metab Brain Dis; 2020 Dec; 35(8):1241-1250. PubMed ID: 32681467 [TBL] [Abstract][Full Text] [Related]
19. Quercetin reduces eIF2α phosphorylation by GADD34 induction. Hayakawa M; Itoh M; Ohta K; Li S; Ueda M; Wang MX; Nishida E; Islam S; Suzuki C; Ohzawa K; Kobori M; Inuzuka T; Nakagawa T Neurobiol Aging; 2015 Sep; 36(9):2509-18. PubMed ID: 26070242 [TBL] [Abstract][Full Text] [Related]
20. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence. Kindy MS; Yu J; Zhu H; El-Amouri SS; Hook V; Hook GR J Alzheimers Dis; 2012; 29(4):827-40. PubMed ID: 22337825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]